BeOne Medicines Market Sentiment

BeOne Medicines Ltd

ONCNASDAQ

$370.33

-1.23-0.33%

Últ. Act.: Nov 2, 7:00 AM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ganancias: Beneficios de Q3 2026 dentro de 3 días de ahora en jue nov 5th, antes de la apertura del mercado

Conferencia telefónica: Conferencia telefónica programada para dentro de 3 días a las 8:00 a. m.

Haz clic para ver el webcast

BeOne Medicines Market Sentiment - Benzinga

BeOne Medicines Market Sentiment

Market sentiment signals for BeOne Medicines (ONC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.2% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

20 analysts

Options Flow (P/C)

—

Avg Consensus PT

$387

+5.8%

Highest Price Target

$459

+25.4%

RBC Capital

Lowest Price Target

$311

-15.0%

RBC Capital

Short Interest

2.2%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	RBC Capital	Leonid Timashev—	+25.4%	$450 → $459	Maintained	Outperform
Oct 7, 2026	Truist Securities	Gregory Renza—	+14.8%	$418 → $420	Maintained	Buy
Oct 1, 2026	JP Morgan	Jessica Fye—	+21.6%	$425 → $445	Maintained	Overweight
Sep 10, 2026	Barclays	Etzer Darout—	+13.4%	$407 → $415	Maintained	Overweight
Aug 6, 2026	TD Cowen	Yaron Werber—	+24.0%	$424 → $454	Maintained	Buy
Aug 6, 2026	RBC Capital	Leonid Timashev—	+23.0%	$451 → $450	Maintained	Outperform
Aug 6, 2026	Truist Securities	Gregory Renza—	+14.2%	$416 → $418	Maintained	Buy
Aug 6, 2026	Guggenheim	Michael Schmitz—	+17.5%	$420 → $430	Maintained	Buy
Aug 6, 2026	Barclays	Peter Lawson—	+11.2%	$403 → $407	Maintained	Overweight
Aug 6, 2026	Citizens	Reni J. Benjamin—	+10.7%	$396 → $405	Maintained	Market Outperform
Jul 23, 2026	JP Morgan	Jessica Fye—	+16.1%	$415 → $425	Maintained	Overweight
Jul 14, 2026	Barclays	Peter Lawson—	+10.1%	$409 → $403	Maintained	Overweight
Jul 13, 2026	Jefferies	Faisal Khurshid—	+3.8%	$333 → $380	Upgrade	Hold→Buy
Jul 7, 2026	RBC Capital	Leonid Timashev—	+23.2%	$436 → $451	Maintained	Outperform
Jul 7, 2026	Truist Securities	Gregory Renza—	+13.7%	$413 → $416	Maintained	Buy
Jul 1, 2026	Citizens	Reni J. Benjamin—	+8.2%	$396 → $396	Maintained	Market Outperform
Jun 2, 2026	RBC Capital	Leonid Timashev—	+19.1%	$425 → $436	Maintained	Outperform
May 15, 2026	Leerink Partners	——	+0.3%	$364 → $367	Maintained	Outperform
May 7, 2026	RBC Capital	Leonid Timashev—	+16.1%	$423 → $425	Maintained	Outperform
May 7, 2026	Guggenheim	Michael Schmidt—	+14.8%	$410 → $420	Maintained	Buy
May 7, 2026	Barclays	Peter Lawson—	+11.7%	$405 → $409	Maintained	Overweight
May 7, 2026	Truist Securities	Gregory Renza—	+12.8%	$411 → $413	Maintained	Buy
May 4, 2026	Wells Fargo	Yanan Zhu—	+9.3%	$400	Initiate	Overweight
Mar 27, 2026	Wolfe Research	Kalpit Patel—	-7.1%	$340	Initiate	Outperform
Mar 16, 2026	Jefferies	Faisal Khurshid—	-20.8%	$420 → $290	Downgrade	Buy→Hold